Align delivered 2% and 7% growth in revenue and adjusted EPS, respectively, during the third quarter. Both figures landed 1% ahead of FactSet consensus. Align also announced Jennifer Davis as the new chief executive, replacing Joseph Hogan.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling a lion's share of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. Invisalign treats over 2 million cases annually, or roughly 10% of all orthodontic cases and has treated over 20 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.